Mitsubishi UFJ Asset Management Co. Ltd. Has $23.44 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Mitsubishi UFJ Asset Management Co. Ltd. raised its position in The Cooper Companies, Inc. (NASDAQ:COO) by 386.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 231,040 shares of the medical device company’s stock after buying an additional 183,581 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Cooper Companies were worth $23,441,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in Cooper Companies by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 5,732,473 shares of the medical device company’s stock valued at $2,169,397,000 after buying an additional 56,911 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Cooper Companies by 273.8% during the first quarter. Bank of New York Mellon Corp now owns 1,731,194 shares of the medical device company’s stock worth $175,647,000 after purchasing an additional 1,268,109 shares in the last quarter. Congress Asset Management Co. MA lifted its position in shares of Cooper Companies by 252.4% during the first quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after purchasing an additional 905,173 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Cooper Companies by 16.5% during the fourth quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after purchasing an additional 140,700 shares in the last quarter. Finally, Jennison Associates LLC lifted its position in shares of Cooper Companies by 200.2% during the first quarter. Jennison Associates LLC now owns 877,295 shares of the medical device company’s stock worth $89,010,000 after purchasing an additional 585,016 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Trading Up 0.4 %

Shares of COO traded up $0.36 on Thursday, reaching $91.32. 1,463,832 shares of the company’s stock were exchanged, compared to its average volume of 1,133,470. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $104.07. The company has a current ratio of 1.95, a quick ratio of 1.14 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $18.18 billion, a P/E ratio of 53.78, a price-to-earnings-growth ratio of 2.23 and a beta of 0.98. The business has a 50 day moving average price of $91.89 and a two-hundred day moving average price of $94.34.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 30th. The medical device company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The firm had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same quarter in the prior year, the firm earned $0.77 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. Research analysts anticipate that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

COO has been the topic of a number of research reports. Robert W. Baird upped their target price on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their target price for the stock from $107.00 to $115.00 in a research report on Tuesday. Piper Sandler reiterated an “overweight” rating and set a $115.00 target price on shares of Cooper Companies in a research report on Wednesday, July 3rd. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Finally, Citigroup upped their target price on shares of Cooper Companies from $108.00 to $116.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $111.78.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.